Improving Healthcare Access with Digital Apps: Insights from Tomas Iglesias
Welcome to the Pharma Sales & Tech podcast by Platforce, where we explore the latest trends and innovations in the pharmaceutical industry. In this episode, we're joined by Tomas Iglesias, co-founder of Zubia, a digital health startup that is changing the way people access healthcare services. Tomas shares his insights on how digital apps are revolutionizing healthcare and the challenges and opportunities he sees in this space.
Key Takeaways:
- Digital apps are transforming healthcare by making it more accessible and convenient for patients.
- Zubia's platform connects patients with healthcare providers and enables them to book appointments, access telemedicine services, and manage their health data.
- The COVID-19 pandemic has accelerated the adoption of digital health solutions, but there are still challenges around regulation and privacy that need to be addressed.
- The future of digital health is exciting, with the potential to improve patient outcomes, reduce costs, and create more personalized and effective healthcare experiences.
Episode Highlights:
- Tomas shares his background and how he came to co-found Zubia.
- He explains how Zubia's platform works and the benefits it provides for patients and healthcare providers.
- Tomas discusses the impact of the COVID-19 pandemic on the digital health industry and the opportunities it has created.
- He shares his insights on the regulatory and privacy issues facing digital health startups and how Zubia is addressing them.
- Tomas talks about the future of digital health and the innovations he sees on the horizon.
Thanks for listening to this episode of the Pharma Sales & Tech podcast by Platforce. We hope you found it informative and insightful. To learn more about Zubia and their mission to revolutionize access to healthcare, visit their website at zubia.life. And don't forget to subscribe to our podcast to stay up-to-date on the latest trends and innovations in the pharmaceutical industry.